Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells - Singh, Shilpi; Maurya, Akhilesh Kumar; Meena, Abha; Mishra, Nidhi; Luqman, Suaib (Biochimica et biophysica acta. General subjects, 2023)
Keywords: Cancer chemoprevention; Cyclooxygenase 2; Flavanones - pharmacology; Humans; Lipoxygenase - therapeutic use; Lipoxygenase-5, Cyclooxygenase-2; MDAMB-231; Molecular Docking Simulation; Narirutin; Ornithine Decarboxylase; Triple Negative Breast Neoplasms - metabolism; Triple-negative breast cancer; Cancer chemoprevention; Lipoxygenase-5, Cyclooxygenase-2; SRB; BBB; SPARC; DMSO; NaOH; FACS; MTT; Triple-negative breast cancer; PDB; MTX; NRU; DMEM; MDAMB-231; FBS; IC50; Ab/Am; GSH; PBS; PGE2; PEP-A; SOD; Narirutin; TCA; HEPES; PI; DFMO; GAPDH; PCR